139 related articles for article (PubMed ID: 6063011)
21. Suppression of xenogeneic local graft versus host reaction by rat fetal spleen cells.
Skowron-Cendrzak A; Rybczyńska Z; Sajak A; Dobrowolski Z
Arch Immunol Ther Exp (Warsz); 1984; 32(4):443-6. PubMed ID: 6534317
[TBL] [Abstract][Full Text] [Related]
22. The significance of small bowel resistance to tumor growth: an experimental study.
Ortiz VN
J Surg Res; 1979 Jun; 26(6):693-7. PubMed ID: 449303
[No Abstract] [Full Text] [Related]
23. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
Ujházy V
Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
[No Abstract] [Full Text] [Related]
24. Analysis of anti-transplantation immunity of tumor.
Ito T
Acta Pathol Jpn; 1968 May; 18(2):207-25. PubMed ID: 5755103
[No Abstract] [Full Text] [Related]
25. [On defined tumor-tolerant and tumor-resistant strains of CFN rats. (Genetic and immunobiological problems in the transplantation of Walker-256 carcinosarcoma in various homologous hosts)].
Lehmann FE; Meyer V
Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1963; 38(3-4):242-52. PubMed ID: 5899906
[No Abstract] [Full Text] [Related]
26. Effects of various dietary fatty acids on enzyme activities of carbohydrate and glutamine metabolism and the metabolic response of lymphocytes and macrophages during Walker-256 ascites cell tumour growth in rats.
Rosa LF; Guimaraes AR; Safi DA; Curi R; Williams JF
Biochem Mol Biol Int; 1993 Jan; 29(1):33-45. PubMed ID: 8490566
[TBL] [Abstract][Full Text] [Related]
27. [Histoenzymatic modifications of the graft and the reactional tissue of the host during the development of fibrosarcoma in the rat].
Catayee G; Senelar R; Bicchieray L; Poli A; Gutierrez A
Ann Histochim; 1968; 13(3):165-9. PubMed ID: 5717660
[No Abstract] [Full Text] [Related]
28. Induction of tolerance to tumour heterotransplantion.
Suciu-Foca N; Nachtigal M
Folia Biol (Praha); 1967; 13(5):350-5. PubMed ID: 5583660
[No Abstract] [Full Text] [Related]
29. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
Nanishi F; Nomoto K; Taniguchi K; Kubo C
Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
[TBL] [Abstract][Full Text] [Related]
30. Helper factor(s) generated by tumor-immune rats for lymphoproliferative responses to syngeneic tumor cells.
Hollingsworth MA; Evans DL
J Natl Cancer Inst; 1984 Jun; 72(6):1357-63. PubMed ID: 6233443
[TBL] [Abstract][Full Text] [Related]
31. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis.
Yao YM; Liu QG; Yang W; Zhang M; Ma QY; Pan CE
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):242-6. PubMed ID: 14599977
[TBL] [Abstract][Full Text] [Related]
32. [Ratio of "light" and "dark" cells in heterogineous cell populations of experimental tumors and their metastases].
Pogodina LS; Kolomina SM; Chentsov IuS
Tsitol Genet; 1983; 17(4):13-9. PubMed ID: 6623627
[TBL] [Abstract][Full Text] [Related]
33. Effect of enzymatic removal of cell surface sialic acid on the adherence of Walker 256 tumor cells to mesothelial membrane.
Cormack D
Cancer Res; 1970 May; 30(5):1459-66. PubMed ID: 5426949
[No Abstract] [Full Text] [Related]
34. Inducing tumor immunity by specific tumor antigens.
Schwind JV
Oncology; 1975; 32(5-6):324-6. PubMed ID: 1228544
[TBL] [Abstract][Full Text] [Related]
35. Heterotransplantation of tumours. IX. Conditioning of the recipient-checking of the effectiveness of suppression in vitro.
Oravec C; Cambelová J; Sakalová A; Ondrus B
Neoplasma; 1972; 19(5):531-45. PubMed ID: 4404913
[No Abstract] [Full Text] [Related]
36. [Characterization study of the autoantigenic reaction between serum and spleen in rats].
Dufour D; Tremblay A
Bull Assoc Fr Etud Cancer; 1965; 52(2):179-84. PubMed ID: 5847732
[No Abstract] [Full Text] [Related]
37. Macrocolony assays in the rat of allogeneic Y-P388 and W-256 tumour cells injected intravenously: dependence of colony forming efficiency on age of host and immunity.
Van den Brenk HA; Sharpington C; Orton C
Br J Cancer; 1973 Feb; 27(2):134-52. PubMed ID: 4694386
[TBL] [Abstract][Full Text] [Related]
38. [Immunological studies on the Walker-carcinoma and the Yoshida-sarcoma].
Scheiffarth F; Warnatz H; Götz H; Rohrwasser M
Z Krebsforsch; 1967; 70(2):178-85. PubMed ID: 4232917
[No Abstract] [Full Text] [Related]
39. Study of destructive mechanisms of the immune response to sarcoma I allograft in mice.
Vidrnová M; Nouza K; Nĕmec M
Neoplasma; 1984; 31(4):369-80. PubMed ID: 6472512
[TBL] [Abstract][Full Text] [Related]
40. [On the presumed antiblastic activity of lysozyme].
Stefani M; Corradi G; D'Amico D
Acta Chir Ital; 1966; 22 Suppl 1():59-67. PubMed ID: 5988821
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
